Obtaining informed consent for clinical tumor and germline exome sequencing of newly diagnosed childhood cancer patients

Míreanna Comhchosúla

• Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors
  le: Parsons, D. Williams, et al.
  Foilsithe: (2016)
• Pediatric cancer genetics research and an evolving preventive ethics approach for return of results after death of the subject
  le: Scollon, Sarah, et al.
  Foilsithe: (2015)
• Is Whole Exome Sequencing an Ethically Disruptive Technology? Perspectives of Pediatric Oncologists and Parents of Pediatric Patients with Solid Tumors
  le: McCullough, Laurence B., et al.
  Foilsithe: (2015)
• TBIO-20. CLINICAL TUMOR WHOLE EXOME SEQUENCING FOR PEDIATRIC NEURO-ONCOLOGY PATIENTS – RESULTS FROM THE BAYLOR ADVANCING SEQUENCING IN CHILDHOOD CANCER CARE (BASIC3) CLINICAL SEQUENCING STUDY
  le: Lin, Frank, et al.
  Foilsithe: (2018)
• Integrated tumor and germline whole-exome sequencing identifies mutations in MAPK and PI3K pathway genes in an adolescent with rosette-forming glioneuronal tumor of the fourth ventricle
  le: Lin, Frank Y., et al.
  Foilsithe: (2016)